All Comments by John Olney

  1. Decreased immunosuppressive effect of cortisol on natural killer cytotoxic activity in senile dementia of the Alzheimer type.
  2. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.
  3. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress.
  4. Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils.
  5. Involvement of neuronal anion exchange proteins in cell death in Alzheimer's disease.
  6. Advanced glycation endproducts in ageing and Alzheimer's disease.
  7. The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?
  8. Transcription factor NF-kappaB: friend or foe of neurons?
  9. Presenilins upregulate functional K+ channel currents in mammalian cells.
  10. Protein nitration in Parkinson's disease.
  11. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.
  12. High affinity glutamate transporters: regulation of expression and activity.
  13. beta-Amyloid peptide-induced morphological changes coincide with increased K+ and Cl- channel activity in rat cortical astrocytes.
  14. Alternative splicing of the glutamate transporter EAAT2 (GLT-1).
  15. Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: attenuated effects in human 1321N1 astrocytoma cells.